Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, anticancer evaluation, and in silico studies of some thieno[2,3‐d]pyrimidine derivatives as EGFR inhibitors
Menna Tallah M. Sayed, Peter A. Halim, Afaf K. El‐Ansary, et al.
Drug Development Research (2023) Vol. 84, Iss. 6, pp. 1299-1319
Closed Access | Times Cited: 8

Showing 8 citing articles:

Thiazolation of phenylthiosemicarbazone to access new thiazoles: anticancer activity and molecular docking
Walid E. Elgammal, Safaa S. Shaban, Essam M. Eliwa, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 12, pp. 1219-1237
Closed Access | Times Cited: 2
Novel pyrazolo[3,4-d]pyrimidine derivatives: design, synthesis, anticancer evaluation, VEGFR-2 inhibition, and antiangiogenic activity
Ahmed M. Abdelhamed, Rasha A. Hassan, Hanan H. Kadry, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 12, pp. 2640-2657
Open Access | Times Cited: 6
Recent Advances in Nanocatalyzed One-Pot Sustainable Synthesis of Bioactive N, N-Heterocycles with Anticancer Activities: An Outlook of Medicinal Chemistry
Sasadhar Majhi
Current Topics in Medicinal Chemistry (2024) Vol. 25, Iss. 1, pp. 63-95
Closed Access | Times Cited: 1
Design, synthesis, and biological evaluation of novel thiazole derivatives as PI3K/mTOR dual inhibitors.
Samar I. Faggal, Yara El‐Dash, Amr Sonousi, et al.
RSC Medicinal Chemistry (2024)
Closed Access | Times Cited: 1
New S‐substituted‐3‐phenyltetrahydrobenzo[4,5]thieno[2,3‐d]pyrimidin‐4(3H)‐one scaffold with promising anticancer activity profile through the regulation and inhibition of mutated B‐RAF signaling pathway
Safaa E. Seif, Wagnat W. Wardakhan, Rasha A. Hassan, et al.
Drug Development Research (2024) Vol. 85, Iss. 7
Open Access | Times Cited: 1
Design and investigation of interactions of novel peptide conjugates of purine and pyrimidine derivatives with EGFR and its mutant T790M/L858R: an in silico and laboratory study
Hannah L. Hunt, Beatriz G. Goncalves, Mary A. Biggs, et al.
Molecular Diversity (2024)
Closed Access
Design, synthesis, biological evaluation, and docking studies of novel triazolo[4,3-b]pyridazine derivatives as dual c-Met/Pim-1 potential inhibitors with antitumor activity
Mohamed E. Mahmoud, Eman Ahmed, Hamdy M. Ragab, et al.
RSC Advances (2024) Vol. 14, Iss. 41, pp. 30346-30363
Open Access
Advances in structural identification of some thieno[2,3-d]pyrimidine scaffolds as antitumor molecules: Synthetic approaches and control programmed cancer cell death potential
Aml E.-S. Mghwary, Rasha A. Hassan, Peter A. Halim, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 107985-107985
Closed Access
Page 1

Scroll to top